Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing ...

Creating a novel drug has always been a risky endeavor for biopharmaceutical companies. Developers and investors face ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

The US Food and Drug Administration (FDA) has approved numerous anti-diabetic medications (ADMs), of which dipeptidyl peptidase-4 inhibitors (DPP-4is) and glucagon-like peptide-1 receptor agonists ...

A new study found a link between SGLT-2 inhibitors and a significantly lower risk of dementia in people with diabetes. Here's ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate ...

Su Yu-cheng (right)shares his experience of serving as the flag bearer for the Chinese Kendo team during the opening ceremony ...